Watertown Bio Summer Break Quick Hits
Catching up on the latest news as things slow down for the summer.
Neumora's Phase 3 Trial Miss and a Trio of VC Raises
Watertown companies have now raised $245 million in VC funds in 2026
Kestrel's $1.45 billion AbbVie Deal, FDA Approves First Ever PROTAC, and Werewolf Breaks Arsenal Lease.
Plus more details on Windgap's big pharma partnership and a number of people moves.
What we're looking forward to in 2026
Neumora's positive clinical data , new tenants at the Arsenal, and more
Cultivarium's Next Steps
Stratus Therapeutics winding down, Consider the ALS TDI for Giving Tuesday, and more